| Data point 1: Baseline, prior to commencing treatment | Data point 2: 4** weeks into treatment | Data point 3: 8** weeks into treatment | Data point 4: 12 weeks into treatment | Data point 5: 24*** weeks into treatment |
---|---|---|---|---|---|
Clinic Review* | x | Â | Â | x | X |
PS | x | x | x | x | X |
Weight | x | x | x | x | Â |
Blood tests* | x | Â | Â | Â | Â |
Radiology* | x | Â | Â | Â | Â |
EORTC QLQC30. | x | x | x | x | X |
HAD, EQ-5D and Patient Satisfaction Questionnaire | x | x | x | x | X |
CSRI Completion | x | Â | Â | x | Â |
Patient Diary for AE Recording | x | x | x | x | X |
Semi-Structured Interview | x(1 in 10 patients) | Â | Â | x | Â |